Stock CAPSTONE THERAPEUTICS CORP
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Capstone Therapeutics Corp Other OTC

Equities

US14068E1091

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Capstone Holding Corp. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Capstone Holding Corp. Announces Change in Board of Directors
CI
Capstone Holding Corp. Announces CFO Change
CI
Capstone Holding Corp. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Capstone Therapeutics : Holding Corp. Announces Exercise Of Secured Debt And Interest Conversion Option By Majority Shareholder, BP Peptides, LLC
PU
Capstone Therapeutics Corp. announced that it has received $1.498 million in funding
CI
Capstone Therapeutics Corp. acquired an unknown stake Instone Co.
CI
CAPSTONE THERAPEUTICS ANNOUNCES TRANSACTION WITH TOTALSTONE LLC
GL
Capstone Therapeutics Corp. entered into an agreement to acquire an unknown stake in Instone Co.
CI
Capstone Therapeutics Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2019
CI
Capstone Therapeutics Corp. Reports Earnings Results for the First Quarter Ended March 31, 2019
CI
Capstone Therapeutics Corp. Reports Earnings Results for the Full Year Ended December 31, 2018
CI
Capstone Therapeutics Corp. Announces Executive Appointments
CI
Capstone Therapeutics Corp. announced that it expects to receive $1.01 million in funding
CI
Capstone Therapeutics Corp. Announces Resignation of Eric W. Fangmann from the Board of Directors and Audit Committee
CI
Capstone Therapeutics Corp. announced that it has received $1 million in funding from BVF Partners LP
CI
Capstone Therapeutics Corp. announced that it expects to receive $1 million in funding from BVF Partners LP
CI
Capstone Therapeutics Corp. and LipimetiX Development, Inc. Announce Patent Application for Novel, More Potent Chimeric Apo E Mimetic Peptides
CI
Capstone Therapeutics Qualifies Fangmann to Serve on the Company’s Board
CI
Capstone Therapeutics Corp. Auditor Raises 'Going Concern' Doubt
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CAPS Stock
  4. Stock
  5. News Capstone Therapeutics Corp